Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). 4SC AG's share price for the quarter that ended in Dec. 2025 was €6.466. 4SC AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 13.20 Mil. Therefore, 4SC AG's market cap for the quarter that ended in Dec. 2025 was €85.34 Mil.
4SC AG's quarterly market cap
increased
from Dec. 2024 (€79.14 Mil) to Jun. 2025 (€85.34 Mil) but then
stayed the same
from Jun. 2025 (€85.34 Mil) to Dec. 2025 (€85.34 Mil).
4SC AG's annual market cap
stayed the same
from Dec. 2023 (€79.14 Mil) to Dec. 2024 (€79.14 Mil) but then
increased
from Dec. 2024 (€79.14 Mil) to Dec. 2025 (€85.34 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. 4SC AG's Enterprise Value for Today is €68.79 Mil.
4SC AG (LTS:0R6U) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
4SC AG Market Cap Related Terms
4SC AG Market Cap Historical Data
* Premium members only.
The historical data trend for 4SC AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0R6U vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, 4SC AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4SC AG Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 4SC AG's Market Cap distribution charts can be found below:
* The bar in red indicates where 4SC AG's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
4SC AG's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4SC AG (LTS:0R6U) has a Market Cap of €76.36 Mil as of Jul. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 4SC AG and its competitors.
Is 4SC AG's Market Cap too high?
4SC AG's current Market Cap is €76.36 Mil. Overall, 4SC AG has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 4SC AG's Market Cap compare to VRTX and REGN?
4SC AG's Market Cap of €76.36 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 113.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.11, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on 4SC AG and its competitors. For the Biotechnology industry, the median Market Cap is 113.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4SC AG's current Market Cap is €76.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4SC AG stock overvalued right now?
4SC AG (LTS:0R6U) has a current Market Cap of €76.36 Mil. The stock's GF Value™ is €226.96, compared to a current price of €6.47 — trading 97.2% below its estimated fair value. The current Market Cap is €76.36 Mil. 4SC AG's overall GF Score™ is 8/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For 4SC AG (LTS:0R6U), the current Market Cap is €76.36 Mil as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4SC AG (LTS:0R6U) Overvalued in 2026?
Based on GuruFocus' analysis, 4SC AG stock appears to be undervalued.
The current stock price of €6.47 is trading 97.2% below its estimated GF Value™ of €226.96.
Key valuation signals for LTS:0R6U:
Market Cap: €76.36 Mil
GF Value™: €226.96 vs. price of €6.47 (97.2% below fair value)
No single metric tells the full story. See the LTS:0R6U stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. The geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.
8GF Score
Get the complete analysis for LTS:0R6U
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0R6U has been successfully added to your 
